Burden of stroke in Bangladesh

Authors

  • Md. Nazmul Islam,

    1. Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh
    2. Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author
  • Mohammed Moniruzzaman,

    1. Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh
    2. Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author
  • Md. Ibrahim Khalil,

    1. Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh
    2. Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author
  • Rehana Basri,

    1. School of Dental Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author
  • Mohammad Khursheed Alam,

    1. School of Dental Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author
  • Keat Wei Loo,

    1. Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author
  • Siew Hua Gan

    Corresponding author
    • Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
    Search for more papers by this author

  • Conflicts of interest: None declared.

Correspondence: Siew Hua Gan, Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan 16150, Malaysia.

E-mail: shgan@kck.usm.my

Abstract

Stroke is the third leading cause of death in Bangladesh. The World Health Organization ranks Bangladesh's mortality rate due to stroke as number 84 in the world. The reported prevalence of stroke in Bangladesh is 0·3%, although no data on stroke incidence have been recorded. Hospital-based studies conducted in past decades have indicated that hypertension is the main cause of ischaemic and haemorrhagic stroke in Bangladesh. The high number of disability-adjusted life-years lost due to stroke (485 per 10 000 people) show that stroke severely impacts Bangladesh's economy. Although two non-governmental organizations, BRAC and the Centre for the Rehabilitation of the Paralysed, are actively involved in primary stroke prevention strategies, the Bangladeshi government needs to emphasize healthcare development to cope with the increasing population density and to reduce stroke occurrence.

Ancillary